Načítá se...
Immunodeficiency and autoimmunity during biological disease-modifying antirheumatic drug therapy
Biological disease-modifying antirheumatic drugs target specific components of the immune response related to pathogenesis of autoimmune and inflammatory diseases. Introduction of biologic therapies has enabled better disease control than conventional drugs and thus a reduction in comorbidity and mo...
Uloženo v:
| Vydáno v: | Reumatologia |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6753594/ https://ncbi.nlm.nih.gov/pubmed/31548748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/reum.2019.87616 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|